209 related articles for article (PubMed ID: 17720896)
1. Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes.
Kellogg AP; Wiggin TD; Larkin DD; Hayes JM; Stevens MJ; Pop-Busui R
Diabetes; 2007 Dec; 56(12):2997-3005. PubMed ID: 17720896
[TBL] [Abstract][Full Text] [Related]
2. Peripheral nerve dysfunction in experimental diabetes is mediated by cyclooxygenase-2 and oxidative stress.
Kellogg AP; Pop-Busui R
Antioxid Redox Signal; 2005; 7(11-12):1521-9. PubMed ID: 16356116
[TBL] [Abstract][Full Text] [Related]
3. Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetes.
Kellogg AP; Converso K; Wiggin T; Stevens M; Pop-Busui R
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H453-61. PubMed ID: 19060127
[TBL] [Abstract][Full Text] [Related]
4. Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration.
Pop-Busui R; Marinescu V; Van Huysen C; Li F; Sullivan K; Greene DA; Larkin D; Stevens MJ
Diabetes; 2002 Aug; 51(8):2619-28. PubMed ID: 12145179
[TBL] [Abstract][Full Text] [Related]
5. Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage.
Ho EC; Lam KS; Chen YS; Yip JC; Arvindakshan M; Yamagishi S; Yagihashi S; Oates PJ; Ellery CA; Chung SS; Chung SK
Diabetes; 2006 Jul; 55(7):1946-53. PubMed ID: 16804062
[TBL] [Abstract][Full Text] [Related]
6. Ranirestat Improved Nerve Conduction Velocities, Sensory Perception, and Intraepidermal Nerve Fiber Density in Rats with Overt Diabetic Polyneuropathy.
Asano S; Himeno T; Hayami T; Motegi M; Inoue R; Nakai-Shimoda H; Miura-Yura E; Morishita Y; Kondo M; Tsunekawa S; Kato Y; Kato K; Naruse K; Nakamura J; Kamiya H
J Diabetes Res; 2019; 2019():2756020. PubMed ID: 31828158
[TBL] [Abstract][Full Text] [Related]
7. The role of nerve inflammation and exogenous iron load in experimental peripheral diabetic neuropathy (PDN).
Baum P; Kosacka J; Estrela-Lopis I; Woidt K; Serke H; Paeschke S; Stockinger M; Klöting N; Blüher M; Dorn M; Classen J; Thiery J; Bechmann I; Toyka KV; Nowicki M
Metabolism; 2016 Apr; 65(4):391-405. PubMed ID: 26975531
[TBL] [Abstract][Full Text] [Related]
8. Effects of the diacylglycerol complexing agent, cremophor, on nerve-conduction velocity and perfusion in diabetic rats.
Jack AM; Cameron NE; Cotter MA
J Diabetes Complications; 1999; 13(1):2-9. PubMed ID: 10232703
[TBL] [Abstract][Full Text] [Related]
9. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity.
Drel VR; Mashtalir N; Ilnytska O; Shin J; Li F; Lyzogubov VV; Obrosova IG
Diabetes; 2006 Dec; 55(12):3335-43. PubMed ID: 17130477
[TBL] [Abstract][Full Text] [Related]
10. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis.
Leonelli E; Bianchi R; Cavaletti G; Caruso D; Crippa D; Garcia-Segura LM; Lauria G; Magnaghi V; Roglio I; Melcangi RC
Neuroscience; 2007 Feb; 144(4):1293-304. PubMed ID: 17187935
[TBL] [Abstract][Full Text] [Related]
11. Peripheral neuropathy in mice with neuronal nitric oxide synthase gene deficiency.
Vareniuk I; Pacher P; Pavlov IA; Drel VR; Obrosova IG
Int J Mol Med; 2009 May; 23(5):571-80. PubMed ID: 19360314
[TBL] [Abstract][Full Text] [Related]
12. Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation.
Stavniichuk R; Drel VR; Shevalye H; Maksimchyk Y; Kuchmerovska TM; Nadler JL; Obrosova IG
Exp Neurol; 2011 Jul; 230(1):106-13. PubMed ID: 21515260
[TBL] [Abstract][Full Text] [Related]
13. Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.
Vareniuk I; Pavlov IA; Obrosova IG
Diabetologia; 2008 Nov; 51(11):2126-33. PubMed ID: 18802679
[TBL] [Abstract][Full Text] [Related]
14. Peripheral neuropathy in transgenic diabetic mice: restoration of C-fiber function with human recombinant nerve growth factor.
Elias KA; Cronin MJ; Stewart TA; Carlsen RC
Diabetes; 1998 Oct; 47(10):1637-42. PubMed ID: 9753304
[TBL] [Abstract][Full Text] [Related]
15. Sulodexide prevents peripheral nerve damage in streptozotocin induced diabetic rats.
Jin HY; Lee KA; Song SK; Liu WJ; Choi JH; Song CH; Baek HS; Park TS
Eur J Pharmacol; 2012 Jan; 674(2-3):217-26. PubMed ID: 21641343
[TBL] [Abstract][Full Text] [Related]
16. Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation.
Lauria G; Lombardi R; Borgna M; Penza P; Bianchi R; Savino C; Canta A; Nicolini G; Marmiroli P; Cavaletti G
J Peripher Nerv Syst; 2005 Jun; 10(2):202-8. PubMed ID: 15958131
[TBL] [Abstract][Full Text] [Related]
17. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy.
Stevens MJ; Obrosova I; Cao X; Van Huysen C; Greene DA
Diabetes; 2000 Jun; 49(6):1006-15. PubMed ID: 10866054
[TBL] [Abstract][Full Text] [Related]
18. Diabetic neuropathy: electrophysiological and morphological study of peripheral nerve degeneration and regeneration in transgenic mice that express IFNbeta in beta cells.
Serafín A; Molín J; Márquez M; Blasco E; Vidal E; Foradada L; Añor S; Rabanal RM; Fondevila D; Bosch F; Pumarola M
Muscle Nerve; 2010 May; 41(5):630-41. PubMed ID: 19918773
[TBL] [Abstract][Full Text] [Related]
19. The role of dietary non-heme iron load and peripheral nerve inflammation in the development of peripheral neuropathy (PN) in obese non-diabetic leptin-deficient ob/ob mice.
Kosacka J; Woidt K; Toyka KV; Paeschke S; Klöting N; Bechmann I; Blüher M; Thiery J; Ossmann S; Baum P; Nowicki M
Neurol Res; 2019 Apr; 41(4):341-353. PubMed ID: 30638160
[TBL] [Abstract][Full Text] [Related]
20. Insulin Treatment Attenuates Small Nerve Fiber Damage in Rat Model of Type 2 Diabetes.
Andreasen LJ; Kirk RK; Fledelius C; Yorek MA; Lykkesfeldt J; Akerstrom T
J Diabetes Res; 2020; 2020():9626398. PubMed ID: 32832565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
